Polymeric Systems for Cancer Immunotherapy: A Review
Thai Minh Duy Le1, A-Rum Yoon1,2,3, Thavasyappan Thambi1
1Department of Bioengineering, College of Engineering, Hanayang University, Seoul, South Korea.
Frontiers in Immunology
|March 11, 2022
Summary
Polymeric systems enhance cancer immunotherapy by improving efficacy and safety. This review explores their use with immune checkpoint inhibitors, CAR T-cells, and oncolytic viruses for better cancer treatment.
Area of Science:
- Oncology
- Immunology
- Materials Science
- Biotechnology
Background:
- Immunotherapy offers a promising approach to cancer treatment by harnessing the immune system to eliminate tumors.
- Polymeric systems are increasingly utilized in immunotherapy due to their biocompatibility, biodegradability, and versatile fabrication.
- These systems can act as immune stimulants, modulate T cells, deliver therapeutic payloads, or function as artificial antigen-presenting cells.
Purpose of the Study:
- To review the current status of monotherapies involving immune checkpoint inhibitors, chimeric antigen receptor (CAR) T-cell therapy, and oncolytic viruses.
- To explore the integration and combination strategies of these advanced immunotherapies with various polymeric systems.
- To highlight the role of polymeric systems in enhancing the efficacy and safety of cancer immunotherapy.
Main Methods:
- Comprehensive literature review of recent studies on immune checkpoint inhibitors, CAR T-cell therapy, and oncolytic viruses in cancer treatment.
- Analysis of research focusing on the application and design of polymeric systems for immunotherapy.
- Examination of combination strategies between polymeric systems and the selected immunotherapeutic agents.
Main Results:
- Immune checkpoint inhibitors, CAR T-cell therapy, and oncolytic viruses have demonstrated significant clinical success as monotherapies.
- Polymeric systems offer tunable properties for optimizing drug delivery, immune cell activation, and overall therapeutic outcomes.
- Combinations of polymeric systems with these immunotherapies show potential for synergistic antitumor effects and improved safety profiles.
Conclusions:
- Polymeric systems are crucial components for advancing cancer immunotherapy, offering multifunctional capabilities.
- The synergistic combination of polymeric systems with immune checkpoint inhibitors, CAR T-cells, and oncolytic viruses represents a key future direction in oncology.
- Further research into tailored polymeric system design is essential for maximizing the potential of next-generation cancer immunotherapies.
Related Concept Videos
01:27Tumor Immunotherapy
702
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
702
01:30Cancer Vaccines
539
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
539
02:57Targeted Cancer Therapies
7.9K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.9K
02:50Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
02:49Cancer Therapies
8.0K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.0K